{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:06:13Z","timestamp":1779062773694,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018623","name":"Quanzhou City Science and Technology Program","doi-asserted-by":"publisher","award":["2021N076S"],"award-info":[{"award-number":["2021N076S"]}],"id":[{"id":"10.13039\/501100018623","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45742-4","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T23:18:58Z","timestamp":1779059938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of obesity and endocrine therapy on the prognosis of premenopausal women with HR+HER2-breast cancer: a multi-center retrospective study"],"prefix":"10.1038","volume":"16","author":[{"given":"Weibin","family":"Lian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengye","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"45742_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells12162061","author":"I Glassman","year":"2023","unstructured":"Glassman, I. et al. The role of obesity in breast cancer pathogenesis. Cells https:\/\/doi.org\/10.3390\/cells12162061 (2023).","journal-title":"Cells"},{"key":"45742_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102241","volume":"9","author":"H Wen","year":"2024","unstructured":"Wen, H. et al. Body mass index, weight change, and cancer prognosis: A meta-analysis and systematic review of 73 cohort studies. Esmo Open. 9, 102241 (2024).","journal-title":"Esmo Open."},{"key":"45742_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/annonc\/mdu509","volume":"26","author":"ER Copson","year":"2015","unstructured":"Copson, E. R. et al. Obesity and the outcome of young breast cancer patients in the UK: The Posh study. Ann. Oncol. 26, 101\u2013112 (2015).","journal-title":"Ann. Oncol."},{"key":"45742_CR4","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1002\/cncr.27527","volume":"118","author":"JA Sparano","year":"2012","unstructured":"Sparano, J. A. et al. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 118, 5937\u20135946 (2012).","journal-title":"Cancer"},{"key":"45742_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1879-4","volume":"15","author":"YW Jeon","year":"2015","unstructured":"Jeon, Y. W. et al. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival. BMC Cancer 15, 865 (2015).","journal-title":"BMC Cancer"},{"key":"45742_CR6","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1200\/JCO.2009.27.2021","volume":"28","author":"I Sestak","year":"2010","unstructured":"Sestak, I. et al. Effect of body mass index on recurrences in Tamoxifen and Anastrozole treated women: An exploratory analysis from the ATAC trial. J. Clin. Oncol. 28, 3411\u20133415 (2010).","journal-title":"J. Clin. Oncol."},{"key":"45742_CR7","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1200\/JCO.2010.33.2585","volume":"29","author":"G Pfeiler","year":"2011","unstructured":"Pfeiler, G. et al. Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the prospective Abcsg-12 trial. J. Clin. Oncol. 29, 2653\u20132659 (2011).","journal-title":"J. Clin. Oncol."},{"key":"45742_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.37780","volume":"6","author":"S Harborg","year":"2023","unstructured":"Harborg, S. et al. Obesity and risk of recurrence in patients with breast cancer treated with aromatase inhibitors. JAMA Netw. Open. 6, e2337780 (2023).","journal-title":"JAMA Netw. Open."},{"key":"45742_CR9","first-page":"e1695","volume":"6","author":"Y Ozaki","year":"2023","unstructured":"Ozaki, Y. et al. The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor-positive breast cancer: A single-Institute retrospective study. Cancer Rep. Us. 6, e1695 (2023).","journal-title":"Cancer Rep. Us."},{"key":"45742_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamaoncol.2018.5327","volume":"5","author":"NM Iyengar","year":"2019","unstructured":"Iyengar, N. M. et al. Association of body fat and risk of breast cancer in postmenopausal women with normal body mass index: A secondary analysis of a randomized clinical trial and observational study. Jama Oncol. 5, 155\u2013163 (2019).","journal-title":"Jama Oncol."},{"key":"45742_CR11","doi-asserted-by":"publisher","first-page":"pkad092","DOI":"10.1093\/jncics\/pkad092","volume":"7","author":"S Lammers","year":"2023","unstructured":"Lammers, S. et al. The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer. JNCI Cancer SPECTR. 7, pkad092 (2023).","journal-title":"JNCI Cancer SPECTR."},{"key":"45742_CR12","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.7150\/jca.59133","volume":"12","author":"YC Lin","year":"2021","unstructured":"Lin, Y. C., Cheng, H. H., Chen, S. C., Shen, W. C. & Huang, Y. T. Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer. J. Cancer 12, 4488\u20134496 (2021).","journal-title":"J. Cancer"},{"key":"45742_CR13","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/iub.2305","volume":"72","author":"S Sadegh-Nejadi","year":"2020","unstructured":"Sadegh-Nejadi, S. et al. Influence of plasma circulating exosomes obtained from obese women on tumorigenesis and Tamoxifen resistance in Mcf-7 cells. IUBMB Life 72, 1930\u20131940 (2020).","journal-title":"IUBMB Life"},{"key":"45742_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1749-6632.2011.06096.x","volume":"1229","author":"AE Harvey","year":"2011","unstructured":"Harvey, A. E., Lashinger, L. M. & Hursting, S. D. The growing challenge of obesity and cancer: An inflammatory issue. Ann. N. Y. Acad. Sci. 1229, 45\u201352 (2011).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"45742_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091472","author":"H Lee","year":"2022","unstructured":"Lee, H. Obesity-associated cancers: Evidence from studies in mouse models. Cells https:\/\/doi.org\/10.3390\/cells11091472 (2022).","journal-title":"Cells"},{"key":"45742_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/ERC-11-0102","volume":"18","author":"Q Zheng","year":"2011","unstructured":"Zheng, Q. et al. Leptin deficiency suppresses Mmtv-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. Endocr. Relat. Cancer. 18, 491\u2013503 (2011).","journal-title":"Endocr. Relat. Cancer."},{"key":"45742_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55674-x","volume":"9","author":"RL Linares","year":"2019","unstructured":"Linares, R. L., Benitez, J., Reynoso, M. O., Romero, C. G. & Sandoval-Cabrera, A. Modulation of the Leptin receptors expression in breast cancer cell lines exposed to Leptin and Tamoxifen. Sci. Rep. 9, 19189 (2019).","journal-title":"Sci. Rep."},{"key":"45742_CR18","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.1200\/JCO.23.00126","volume":"41","author":"G Pfeiler","year":"2023","unstructured":"Pfeiler, G. et al. Impact of Bmi in patients with early hormone receptor-positive breast cancer receiving endocrine therapy with or without Palbociclib in the Pallas trial. J. Clin. Oncol. 41, 5118\u20135130 (2023).","journal-title":"J. Clin. Oncol."},{"key":"45742_CR19","first-page":"19","volume":"63","author":"CY Li","year":"2016","unstructured":"Li, C. Y. & Chen, M. L. [Chemotherapy-induced amenorrhea and menopause symptoms in women with breast cancer]. Hu Li Za Zhi 63, 19\u201326 (2016).","journal-title":"Hu Li Za Zhi"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45742-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45742-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45742-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T23:18:59Z","timestamp":1779059939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45742-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45742"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45742-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of Quanzhou First Hospital, Affiliated with Fujian Medical University (Approval No. 2026-K073). The requirement for informed consent was waived due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"15281"}}